MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Outpatient Interventional Oncology: Primum Non Nocere
Top tips for treating patients and avoiding complications in the outpatient setting.
By Edgar D. St. Amour, MD; David Hays, MD; and Ripal T. Gandhi, MD, FSIR, FSVM
Pivotal Trial Begins for Instylla’s Embrace Hydrogel Embolic System to Treat Hypervascular Tumors
March 30, 2021—Instylla, Inc. announced the enrollment of the first patients in the pivotal Embrace Hydrogel Embolic System (HES) global randomized clinical trial for the treatment of hypervascular tumors.
Enhancing Interventional Oncology
By Ripal T. Gandhi, MD, FSIR, FSVM, and David M. Liu, MD, FRCPC, FSIR
